Skip to main content

Healthcare Finance Staff

By Healthcare Finance Staff | 11:40 am | October 02, 2014
Here's a tangled web: It appears that some of the federal government's profit-loss payments to insurers are at once obligated and prohibited.
By Healthcare Finance Staff | 05:22 pm | October 01, 2014
United Healthcare's shopping spree continues, as it acquires a Texas company with practice management, revenue cycle, physician referral management and other ambulatory-focused technology.
By Healthcare Finance Staff | 11:19 am | October 01, 2014
The traditional health insurance business model is on the verge of a cataclysmic shift toward individual consumers. While that will require moving away from the old IT running within many payers, it also makes now a great time for reinvention, venture capitalists argue, if not the only opportunity.
By Healthcare Finance Staff | 03:32 pm | September 30, 2014
Health insurer spending on treatment for painkiller dependence is on the rise, and proving to be one of several tools needed to curb the epidemic of opioid addiction.
By Healthcare Finance Staff | 11:53 am | September 30, 2014
Health insurers are betting on value-based payments, broadly defined, but providers still seem skittish.
By Healthcare Finance Staff | 10:19 am | September 30, 2014
Don't rule out chaos for next year's ICD-10 deadline, or maybe plan on it, if the latest readiness research is any indication. 
By Healthcare Finance Staff | 10:12 am | September 30, 2014
Rethinking how it acquires information technologies seems to be giving one insurer an edge, letting it eke out a "trifecta" of lower costs, fewer unhappy customers, and increased revenue.
By Healthcare Finance Staff | 05:27 pm | September 29, 2014
Network adequacy concerns are starting to generate renewed interest in new health plan provider mandates.
By Healthcare Finance Staff | 01:26 pm | September 29, 2014
The parallels between the nation's ICD-10 switch and the popular fantasy epic are real.
By Healthcare Finance Staff | 01:00 pm | September 29, 2014
Advances in molecular and genomic technology are creating a maze of new options for payers and patients replete with quite a few meaningful improvements as well as some dead ends.